You are here:

  1. Home
  2. NICE Guidance
  3. Health and social care delivery
  4. Acute and critical care

Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care

  • Medical technologies guidance
  • Reference number: MTG65
  • Published:  27 January 2022

Register as a stakeholder

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Research recommendations coming out of this guidance

  • Further research is recommended to identify any health conditions or groups of patients that would benefit more from inhaled sedation with Sedaconda ACD-S than from standard care

Back to top